CHEMOPROPHYLAXIS;
HUMAN;
MALARIA;
MALARIA CONTROL;
PLASMODIUM FALCIPARUM;
SHORT SURVEY;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG INDUSTRY;
DRUG RESISTANCE;
PRACTICE GUIDELINE;
REVIEW;
ANTIMALARIALS;
ARTEMISININS;
CHLOROGUANIDE;
CHLOROQUINE;
DRUG APPROVAL;
DRUG COMBINATIONS;
DRUG INDUSTRY;
DRUG RESISTANCE;
GUIDELINES;
HUMANS;
SESQUITERPENES;
Multi-drug falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance
Brasseur P, Kouamouo J et al. Multi-drug falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg 1992; 46: 8-14.
Overview of the results obtained with IM artemether in the treatment of severe falciparum malaria
Ambroise-Thomas P. Overview of the results obtained with IM artemether in the treatment of severe falciparum malaria. Jpn J Trop Med Hyg 1996; 24: 87-91.
Clinical pharmacology and therapeutic potential of Artemisinin and its derivatives in the treatment of malaria
De Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of Artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818-36.
Interactions between docetaxel (Taxotere) and Plasmodium falciparum infected erythrocytes
Schrevel J, Sinou V et al. Interactions between docetaxel (Taxotere) and Plasmodium falciparum infected erythrocytes. Proc Natl Acad Sci USA 1994; 91: 8472-6.
Plasmodium phospholipid metabolism: A target for the drug development of novel antimalarial drugs
Vial H, Ancelin ML et al. Plasmodium phospholipid metabolism: a target for the drug development of novel antimalarial drugs. J Trop Med Parasitol 1997; 91: S 87-S 90.
Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria
Waesame M, Wernsdorfer WH et al. Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. Trans Roy Soc Trop Med Hyg 1992; 86: 235-6.
A novel pyrrolidonoalkaneamine (WR 268, 954) that modulates chloroquino-resistance of Plasmodium falciparum in vitro
De D, Bhaduri AP et al. A novel pyrrolidonoalkaneamine (WR 268, 954) that modulates chloroquino-resistance of Plasmodium falciparum in vitro. Am J Trop Med Hyg 1993; 49: 113-20.